
Our publications are tailored to the needs of specific audiences and published in a variety of print or web formats. More..
EMCDDA data and information can be reproduced and cited, provided that there is a clear indication of the source. More..
Find an overview of upcoming EMCDDA publications.
Printed publications can be directly ordered from the EU Bookshop.
You can also subscribe to receive the publication series Annual report, Drugnet Europe and Drugs in focus in printed format regularly. More...

Use the options below to search for publications of interest in our publications database. You can search by publication series, publication type, date published, and keywords. You can also use the search box to search for specific text.
2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996
Annual report | Drugnet Europe | Drug policy profiles | Drugs in focus | Implementation reports | Insights | Joint publications | Joint reports | Literature reviews | Manuals | Monographs | National reports | Risk assessments | Selected issues | Technical data sheets | Thematic papers
Annual accounts | Brochures | Budget | General report of activities | Work programmes
A-D amphetamines | alcohol | cannabis | cocaine | co-morbidity | consumption rooms | crime | death | demand | driving | drug-law offences
E-H EMCDDA | environmental indicators | epidemiology | evaluation | gender | hallucinogens | harm reduction | health effects | heroin | history | HIV
I-O infectious diseases | injecting | key indicators | law | methodology | markets | new drugs | older people | opioids | overdose
P-R policy | polydrug use | prevalence | prevention | prison | price | problem drug use | public expenditure | purity | recreational drugs | research | risk behaviour
S school/students | seizures | social exclusion | social reintegration | spice | strategies | substitution treatment | supply | synthetic stimulants
T-Z trafficking | treatment | trends | young people
HIV in injecting drug users in the EU/EEA
January 2012
In response to a notified increase in HIV cases among injecting drug users (IDU) in Greece and Romania, the European Commission asked the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in November 2011 to conduct a rapid inquiry among their network of HIV surveillance- and drug focal points to investigate whether such increases had occurred in other countries.
Kosovo (under UNSCR 1244/99): country overview 2010
December 2011 This report provides a structured synopsis of the trends and characteristics of national drug problems in Kosovo (under UNSCR 1244/99) in 2010.
This joint publication with the European Police Agency, Europol, is an in-depth study on the illicit market in amphetamine. Bringing together data on law enforcement measures such as drug seizures and clandestine laboratory detections with data on drug use prevalence, the report shows that Europe is the world’s number one producer of amphetamine and a major consumer market.
Responding to new psychoactive substances
December 2011
This briefing paper describes some of the practical and legal obstacles facing Member States when responding to new substances. It underlines the importance of national early-warning systems in detecting, identifying and ultimately controlling, potentially dangerous new drugs.
This Manual is a joint production by the EMCDDA and the Prevention Standards Partnership, and presents and describes basic and expert level quality standards for drug prevention.
2011 Annual report on the state of the drugs problem in Europe
November 2011
The report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the drug phenomenon. This is an essential reference book for policymakers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
This Selected issue focuses on mortality among drug users due to all causes, of which drug-induced deaths (overdoses) is only a component, albeit the one most well-documented.